Schizophrenia often exhibits familial clustering; this is suggestive of heritable factors, but the whereabouts of responsible gene(s) has remained elusive. Recent research suggests that a region of chromosome 6p may hold some of the answers. Approximately one in every 100 individuals will develop schizophrenia during the course of his or her life. The symptoms typically emerge in the late teens and twenties: schizophrenia disrupts an individual's thought processes, perceptions, emotions and behaviour. Sufferers lose touch with reality, developing false beliefs (delusions) and experiencing abnormal perceptions -in particular, auditory hallucinations or 'voices'. They may also show poverty in the amount and content of speech, poor working memory, and inappropriate mood and behaviour. The frequent hospitalizations, profound psychosocial impairment, and high incidence of suicide ensure that schizophrenia is a major public health concern.
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Little is known regarding the aetiology and pathophysiology of the illness, and diagnosis is therefore wholly based on the clinical presentation. The boundaries of schizophrenia are unclear, however, and several 'schizophrenia-like' syndromes exist; such symptoms can be caused by other mental illness, physical illness, prescription medications, illicit drugs or brain injury [1] . Currently, there is no way to prevent or cure schizophrenia, although antipsychotic medications can control some symptoms. Schizophrenia is known to cluster in families, suggesting a genetic contribution to its aetiology. The nature of this contribution is naturally of great interest, but attempts to find responsible gene(s) have so far met with little success. New results suggest such a gene may reside in a region of chromosome 6p.
Genetic epidemiology
Schizophrenia is more common among the relatives of schizophrenics than in the population at large. One of the earliest propronents of a role for genetic factors was Charles Darwin (1809-1882): "With man we see... that genius, which implies a wonderfully complex combination of high faculties, tends to be inherited; and... that insanity and deteriorated mental powers likewise run in families" [2] . Following the delineation of schizophrenia at the turn of this century by Kraepelin and Bleuler, family, twin and adoption studies have added weight to Darwin's observation (reviewed in [3, 4] ). Family studies show that, in aggregate, first-degree relatives of an individual with schizophrenia have approximately ten-times the general population risk of developing the disorder. Modern (after 1967) twin studies show that an identical (monozygotic) twin of someone with schizophrenia exhibits the disorder 50 % of the time, compared with 10 % for a fraternal (dizygotic) twin. Similarly, adoption studies have, without exception, found increased rates of schizophrenia in the biological relatives of schizophrenic adoptees but not in their adoptive relatives.
Although a large literature discusses the weaknesses of such behavioural genetic studies of schizophrenia, in aggregate they suggest that shared genes rather than shared environments underlie the increased risk of illness in the relatives of affected individuals. The genetic contribution to schizophrenia -its heritability -has been estimated to be ~70 %; this leaves room for environmental mechanisms also. Gene-environment interactions are therefore likely; for example, a Danish study found that the risk of schizophrenia to the children of unaffected monozygotic co-twins equalled that of the affected twins' offspring [5] . This lack of penetrance of the genetic factor(s) in the unaffected twin could possibly be due to a lack of interaction with a specific environmental agent. Hence, what is inherited is not the certainty of disease accompanying a particular genotype but rather a predisposition or liability to develop the disorder. The question then arises as to what the genetic component is.
Mode of inheritance
Known inherited diseases display a variety of transmissible factors (one gene, few genes, polygenes, genes on sex chromosomes), transmission patterns (dominant, recessive), interactions with the environment, and effects of population dynamics on the mutation. Most of the potential modes of inheritance have been suggested, at some time or other, to apply to schizophrenia [1] .
Diseases caused by mutations in single genes are usually relatively rare and show very specific, Mendelian patterns of inheritance. The fact that schizophrenia is relatively common and complex in its pattern of inheritance is not conducive to a single-gene hypothesis, although modifications to Mendelian ratios, such as incomplete penetrance and/or variable expressivity, can occur. Other genetic phenomena -genomic imprinting, anticipation, mitochondrial inheritance or partial sex-linkage -could also be relevant to schizophrenia. Phenocopies -affected individuals without the disease genotype, in whom the disease is caused by environmental factors -may also obscure a Mendelian inheritance pattern. For example, patients with temporal lobe epilepsy may manifest schizophrenic symptoms. In addition, obstetric difficulties before or at the time of the birth have been established as a risk factor, and the abuse of drugs such as LSD (lysergic acid diethylamide) or amphetamines may precipitate the disorder.
An alternative to a single-gene hypothesis is that an unspecified, large number of independently segregating loci ('polygenes') contribute additively to the phenotype. It has been argued [6] , on the basis of animal breeding experiments, as well as human studies, that multiple genes are responsible for the genetic influences on behaviour and that a continuum of genetic risk is likely to extend from normal to abnormal behaviour (including psychiatric illnesses such as schizophrenia). Attempts to determine the mode of transmission of schizophrenia using mathematical models of transmission patterns and segregation studies of families have been inconclusive [4] . The weight of evidence is against a model in which a single gene (a single major locus) is the only source of family resemblance for the schizophrenic phenotypethe risks of schizophrenia in different classes of relative to an affected individual do not conform with those predicted by a simple Mendelian pattern of transmission. This has led to the 'oligogenic' model [7] , in which a small number of genes with multiplicative effects are the determining factors. A single major locus is not, however, rejected as part of a mixed, multifactorial model in which a gene of major effect acts in combination with oligogenes, polygenes and the environment.
Molecular genetic approaches
The exact aetiological role of genetic factors and their pattern of transmission can only be presumed until mutations in specific genetic loci are found in affected persons, obligate carriers and at-risk individuals. A number of molecular genetic methods have been used to try to detect and locate susceptibility loci [8] . Even though a Mendelian, single-gene inheritance pattern is not the norm, some families of this type may exist and affected members may be informative in the search for predisposing loci using positional cloning techniques (reverse genetics). The use of highly familial subforms has proved to be a successful approach in other complex disorders such as Alzheimer's disease, non-insulin-dependent diabetes and breast cancer. The first step is to find a 'linkage' between a polymorphic genetic marker, which defines a region of the genome, and the putative disease locus.
Linkage studies for disease genes examine the segregation of alleles at a marker locus in families containing multiple members affected with the disease. A marker close to, or within, the gene of interest will be passed from parent to child with the gene, and one can therefore use the marker to see whether a particular allele of the gene co-segregates with the disease in affected families. The aim is to detect departure from independent assortment (and hence infer linkage), and to estimate the genetic distance between the two loci. Significant evidence of linkage between a marker and a disease demonstrates the existence of a major locus for the disease, and localizes it to a region for further investigation. The classic way to measure this evidence is by the 'lod' score -the logarithm of the odds ratio (the relative likelihoods of linkage versus no linkage).
The application of the lod-score method to schizophrenia has been fraught with problems, as it requires the use of parameters (gene frequency, penetrance and phenocopy rates) to describe the transmission of the trait. As the mode of transmission of schizophrenia is unknown, a number of different genetic models may be tested in the statistical analysis, increasing the probability of a falsepositive finding. Other problems arise because of uncertainty in diagnostic criteria for affected individuals, genetic heterogeneity, phenocopies and incomplete penetrance. Furthermore, the lod-score method may not be the most appropriate for the analysis of complex genetic disorders if there are no genes of major effect.
One way to overcome the problem of deducing the parameters of transmission is to use allele-sharing methods. Affected relative pairs are used to determine whether the alleles of a marker are shared more often than would be expected by chance; affected relatives should show excess allele sharing even in the presence of incomplete penetrance, genetic heterogeneity and highfrequency disease alleles. Several robust, non-parametric linkage methods have been proposed which are often used with the lod-score method to safeguard against falsenegative findings due to incorrect specification of the inheritance model. By focusing on highly familial subforms of schizophrenia, these linkage methods have been used in attempts to deduce the genetic component of the illness. Initially, studies focused on candidate genes and regions of the genome (reviewed in [3] ). For example, the segregation of chromosome abnormalities with schizophrenia in certain families provided the impetus for researchers to attempt linkage studies of chromosome 5. This led to the emergence, in 1988, of the first claim for the existence of a schizophrenia locus on the long arm (q) of chromosome 5 [9] . Unfortunately, this finding was never confirmed.
Given the complexity and unknown pathogenesis of schizophrenia, it may be more productive to conduct a systematic search of the entire genome as part of a positional cloning strategy. Until recently, the successful dissection of complex traits by genome-wide linkage mapping was restricted to experimental organisms such as mice. When dense maps of highly polymorphic microsatellite markers throughout the human genome became available, systematic genome scans were initiated. Initial results of systematic genomic searches using highly polymorphic, evenly spaced genetic markers found small positive lod scores for markers from the long arm of chromosome 22 [10] . This region maintains interest as replication studies have been supportive, and significant results have been obtained using non-parametric methods in a large collaborative data set [11] .
Chromosome 6p
Recent advances in technology mean that the accuracy, speed and efficiency of genotyping of microsatellite markers can be facilitated by fluorescent labelling and automation. In a pilot test of automated genotyping strategies for a genomic scan, using 186 Irish pedigrees, an Irish-American group of researchers provided the first report of a possible susceptibility locus for schizophrenia on distal chromosome 6p (D6S260) [12] . Although the lod scores were significantly positive, they could still be obtained by chance one in 40 times in a genome scan. Consequently, independent studies were required to provide more convincing evidence.
Moises and colleagues [13] used a genome scan in three phases, in principle providing built-in validation. In the first stage, they used five families with a total of 37 affected individuals from Iceland (a geographic isolate, intended to reduce the possibility of heterogeneity within the sample studied). Screening with 413 markers, and using a non-parametric analysis, produced 26 'interesting' areas for further investigation. Ten of these were selected for the second stage and tested in a total of 65 families from numerous populations. This material revealed some evidence for linkage to four loci. When results from the first and second stages were combined and analyzed, the statistical evidence for linkage increased slightly for loci on chromosomes 6p, 8p and 20. The most stringent significance level could be reached only for 6p, and then only after a third population sample was added -113 schizophrenic patients and their unaffected parents from China.
Markers in this region have also been tested for linkage in an extension of the Irish data set used in the original work implicating 6p [14] . By looking at 265 pedigrees, there is significant evidence, from a lod-score analysis assuming locus heterogeneity, for linkage on 6p. Families from Germany [15] and the United States [16] , tested in two independent studies, also provide suggestive evidence for linkage of a schizophrenia susceptibility locus to this region. Together, these four reports [13] [14] [15] [16] , which take in a total of 430 families from different populations plus 113 schizophrenics with unaffected parents from China, suggest that chromosome 6p does indeed carry a locus that predisposes to schizophrenia. Weight should be given to replication of the finding by several different groups, despite differences in diagnostic schemes and methods of analysis. These studies also show that locus heterogeneity is likely -the presumed gene on 6p is thought to account for the genetic vulnerability to schizophrenia in up to 30 % of the families studied.
The evidence implicating a locus on 6p is the strongest to date in schizophrenia genetics, and efforts are already underway to refine the location and search for coding sequences. The region implicated is, however, quite large (Fig. 1) . The most suggestive lod scores were obtained on two regions some 20 cM apart, probably reflecting different informativeness of the markers in individual data sets and imprecise definition of inheritance pattern, rather than true loci. The combined data suggest a wide region, close to 30 cM long and containing maybe hundreds of genes, at 6p21-24. It is interesting to speculate on what type of gene(s) may have a role in schizophrenia. Will it be one gene, such as a gene encoding a transcription factor that controls the expression of a number of genes? Or will it be a gene with a role in one of the biological theories for schizophrenia -predominantly alterations of neurodevelopment, neurochemistry and immune/autoimmune reactions? It is particularly poignant that the HLA (Human Leukocyte antigen) region, highly involved in immune and autoimmune reactions and shown previously to have allelic associations with schizophrenia, is on the edge of the implicated region. Human chromosome 6, showing genetic markers used in recent studies which indicate that the 6p21-24 region may contain a susceptibility locus for schizophrenia. HLA, human leukocyte antigen.
Other possible loci
One of the assumptions of linkage analysis is that there is a gene of major effect, and that familial schizophrenia may be a subtype. To detect genes of smaller effect, association analysis can be used to compare the frequency of marker alleles in a sample of patients with ethnically matched controls. A significantly higher frequency of the marker allele in the patient group suggests either that the marker itself has some direct influence on susceptibility to the disease or that it is in linkage disequilibrium with a susceptibility locus. Current interest in association studies of schizophrenia focuses on functionally significant variations in candidate genes. For example, following the use of drug treatment for schizophrenia and emergence of the 'dopamine hypothesis', many linkage studies have tried, with no success, to show a major role for the genes encoding the dopamine receptors and dopamine metabolizing enzymes. However, association studies, in particular of the dopamine D3 receptor gene, have been more encouraging. A common variation in the first exon of this gene results in a restriction-fragment length polymorphism; an increased incidence of homozygosity for this polymorphism in schizophrenics compared with controls has been reported by several research groups.
Other recent research suggests that the genetic aetiology of schizophrenia may involve expanded triplet repeats of DNA. Such motifs have been shown for a number of neurological disorders (reviewed in [17] ), and in many cases they are the cause of anticipation (an inheritance pattern within a pedigree wherein disease severity increases or age of onset decreases in successive generations). Recent studies suggesting that anticipation occurs in schizophrenia pedigrees (reviewed in [18] ) replicate a phenomena that was noted as early as 1910 by Mott. However, family studies seeking anticipation are prone to a number of ascertainment biases, and direct evidence for anticipation using molecular genetic methods such as RED (repeat expansion detection) to detect expanded triplet repeats has been sought. Expanded CAG repeats have recently been reported in the DNA of schizophrenic individuals [19] , especially those with an early age of onset of the illness and female patients [20] .
The search for genes predisposing to schizophrenia has been frustrating, and characterized by failure to replicate initial positive linkages. However, contemporary studies have now reached a size and sophistication that command more respect than their precursors. No definite results have yet emerged. However, several 'hot spots' are currently the subject of intensive investigation, the most promising of which is at 6p21-24. Whether the belief that this region contains a major predisposing gene for schizophrenia is a collective delusion or not, should shortly be resolved.
